Your session is about to expire
← Back to Search
Nicotinamide mononucleotide (NMN-C) for Healthy Subjects
Study Summary
This trial is investigating the safety and effects of a 30-day course of nicotinamide mononucleotide (NMN-C) in healthy adults.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do my characteristics meet the criteria to join this medical experiment?
"This clinical trial seeks to recruit 24 participants with healthy BMI between 18.5 and 29.9 kg/m2 that have maintained their weight for the past 3 months (±2kg). Furthermore, post-menopausal women must present evidence of amenorrhea for a year before being eligible; whereas females capable of bearing children are expected to abstain from sexual activity or use effective birth control methods in order to be included in the study. Additionally, all patients will need to adhere to dietary guidelines issued by an assigned nutritionist both during and after completion of the experiment as well as consuming pre-established meals prior specified visits."
Is eligibility limited to those under the age of 25 for this experiment?
"This clinical investigation is open to individuals aged 18 and above, up to the age of 65."
Are there still vacancies in this research program?
"According to clinicaltrials.gov, this research endeavour is not presently enrolling patients; the trial was advertised on August 5th 2021 and its information was last updated on May 31st 2022. Despite that fact, there are currently 839 other studies actively seeking participants."
Share this study with friends
Copy Link
Messenger